Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
Showing 1 - 25 of >10,000
Psoriasis Trial (BI 765250, Placebo)
Not yet recruiting
- Psoriasis
- BI 765250
- Placebo
- (no location specified)
Feb 6, 2023
Psoriasis Trial in Shanghai (IBI112, /IBI112)
Not yet recruiting
- Psoriasis
- IBI112
- placebo /IBI112
-
Shanghai, Shanghai, ChinaShanghai Skin Disease Hospital
Dec 1, 2022
Psorcast Mobile Study
Recruiting
- Psoriatic Arthritis
- +8 more
- Participant self-assessment surveys
- +6 more
-
Seattle, WashingtonSage Bionetworks
Nov 10, 2022
COVID-19 Associated With Psoriasis
Recruiting
- Psoriasis Patients
- COVID-19
-
Chongqing, Chongqing, China
- +11 more
Jul 26, 2023
Psoriasis, Skin Diseases Trial in China (AK111, Placebo)
Active, not recruiting
- Psoriasis
- Skin Diseases
- AK111
- Placebo
-
Bengbu, Anhui, China
- +33 more
Sep 27, 2023
Plaque Psoriasis Trial (Ixekizumab+Jueyin Granules, Ixekizumab+Jueyin Granules)
Not yet recruiting
- Plaque Psoriasis
- Ixekizumab+Jueyin Granules
- Ixekizumab+Jueyin placebo Granules
- (no location specified)
Sep 4, 2021
Associated Burden of Related Conditions in Alopecia Areata
Completed
- Alopecia Areata
- +35 more
- Exposure of interest (studies 2 & 3).
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Plaque Psoriasis Trial in Cairo (Bee venom phonophoresis)
Not yet recruiting
- Plaque Psoriasis
- Bee venom phonophoresis
-
Cairo, EgyptAhmed Mohamed Ahmed Abdelhady
Oct 31, 2023
Psoriasis Trial in Worldwide (Risankizumab, Placebo for Risankizumab)
Active, not recruiting
- Psoriasis
- Risankizumab
- Placebo for Risankizumab
-
Glendale, Arizona
- +54 more
Mar 2, 2022
Psoriasis Trial (Inflammatory skin disease formula, Placebo)
Not yet recruiting
- Psoriasis
- Inflammatory skin disease formula
- Placebo
- (no location specified)
Oct 18, 2022
Psoriasis Vulgaris Trial (SDD formula, Placebo)
Not yet recruiting
- Psoriasis Vulgaris
- SDD formula
- Placebo
- (no location specified)
Apr 4, 2023
Systemic Sclerosis Associated Interstitial Lung Disease Trial (Belimumab, Placebo)
Not yet recruiting
- Systemic Sclerosis Associated Interstitial Lung Disease
- Belimumab
- Placebo
- (no location specified)
May 19, 2023
Plaque Psoriasis, Scalp Psoriasis Trial in United States (Guselkumab, Placebo)
Not yet recruiting
- Plaque Psoriasis
- Scalp Psoriasis
- Guselkumab
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 16, 2022
Psoriasis Trial in Olsztyn (Chicory-derived inulin-type ß-fructans, Maltodextrin)
Enrolling by invitation
- Psoriasis
- Chicory-derived inulin-type β-fructans
- Maltodextrin
-
Olsztyn, Poland
- +1 more
Jul 24, 2023
Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])
Completed
- Scalp Psoriasis
- Tazarotene 0.045% Topical Application Lotion [ARAZLO]
-
Karachi, Sindh, PakistanJPMC
Aug 28, 2023
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)
Not yet recruiting
- Chronic Plaque Psoriasis
- Moderate to Severe Chronic Plaque Psoriasis
- Placebo
- Bimekizumab
- (no location specified)
Aug 21, 2023